Cargando…

ARMC5 mutations are associated with high levels of proliferating cell nuclear antigen and the presence of the serotonin receptor 5HT4R in PMAH nodules

OBJECTIVE: To analyze the morphological and functional characteristics of primary macronodular adrenal hyperplasia (PMAH) nodules carrying or not carrying ARMC5 mutations and the consequences of the presence of mutations in terms of the pattern of macronodule composition and functional state. SUBJEC...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Conceição, Barbara Brito, Cavalcante, Isadora Pontes, Kremer, Jean Lucas, Auricino, Thais Barabba, Bento, Eduarda Corrêa, Zerbini, Maria Claudia Nogueira, Fragoso, Maria Candida Barisson Villares, Lotfi, Claudimara Ferini Pacicco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522072/ https://www.ncbi.nlm.nih.gov/pubmed/32267363 http://dx.doi.org/10.20945/2359-3997000000236

Ejemplares similares

Involvement of JAK-STAT-SOCS3 Pathway in the Regression of Mice X-Zone of Adrenal Cortex
por: Auricino, Thais Barabba, et al.
Publicado: (2021)

SUN-382 Heterogeneous Clinical Presentation In Familial Cases Of Primary Macronodular Adrenal Hyperplasia (PMAH): The Influence Of Somatic Event Of ARMC5.
por: Brondani, Vânia, et al.
Publicado: (2019)

FRI188 Exploratory Genomic Analysis From A Brazilian PMAH-Family With ARMC5 Alteration With Insidious Pattern Progression Of The Disease
por: Charchar, Helaine Laiz, et al.
Publicado: (2023)

Upregulation of TCF21 inhibits migration of adrenocortical carcinoma cells
por: Kremer, Jean Lucas, et al.
Publicado: (2021)

An Overview of the Heterogeneous Causes of Cushing Syndrome Resulting From Primary Macronodular Adrenal Hyperplasia (PMAH)
por: Charchar, Helaine Laiz Silva, et al.
Publicado: (2022)

POD-1/TCF21 Reduces SHP Expression, Affecting LRH-1 Regulation and Cell Cycle Balance in Adrenocortical and Hepatocarcinoma Tumor Cells
por: França, Monica Malheiros, et al.
Publicado: (2015)

TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors
por: Passaia, Barbara dos Santos, et al.
Publicado: (2018)

The human adrenal cortex: growth control and disorders
por: Lotfi, Claudimara Ferini Pacicco, et al.
Publicado: (2018)

ARMC5 Alterations in Primary Macronodular Adrenal Hyperplasia (PMAH) and the Clinical State of Variant Carriers
por: Kyo, Chika, et al.
Publicado: (2019)

The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells
por: Silveira, Elaine, et al.
Publicado: (2018)

New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
por: França, Monica Malheiros, et al.
Publicado: (2017)

The Role of gsp Mutations on the Development of Adrenocortical Tumors and Adrenal Hyperplasia
por: Villares Fragoso, Maria Candida Barisson, et al.
Publicado: (2016)

Comparative Effect of ACTH and Related Peptides on Proliferation and Growth of Rat Adrenal Gland
por: Lotfi, Claudimara Ferini Pacicco, et al.
Publicado: (2016)

Allelic Variants of ARMC5 in Patients With Adrenal Incidentalomas and in Patients With Cushing's Syndrome Associated With Bilateral Adrenal Nodules
por: Mariani, Beatriz Marinho de Paula, et al.
Publicado: (2020)

SAT-147 Endogenous Expression of TCF21 by CRISPR/dCas9 System Results in Different Biological Responses in Adrenocortical Carcinoma and Hepatocarcinoma
por: Kremer, Jean Lucas, et al.
Publicado: (2020)

The Involvement of Nek2 and Notch in the Proliferation of Rat Adrenal Cortex Triggered by POMC-Derived Peptides
por: de Mendonca, Pedro Omori Ribeiro, et al.
Publicado: (2014)

RF09 | PSUN06 ARMC5 as a possible regulator of acetylation in the adrenal cortex in partnership with SIRT1
por: Berthon, Annabel, et al.
Publicado: (2022)

ARMC5 Variants and Risk of Hypertension in Blacks: MH‐GRID Study
por: Zilbermint, Mihail, et al.
Publicado: (2019)

Resolution of Cyclicity After Pasireotide LAR in a Patient With Cushing Disease
por: Machado, Márcio Carlos, et al.
Publicado: (2021)

The Expansion of the Spectrum in Stuttering Disorders to a Novel ARMC Gene Family (ARMC3)
por: Rehman, Adil U, et al.
Publicado: (2022)

ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia
por: Yu, Liping, et al.
Publicado: (2018)

Armc5 deletion causes developmental defects and compromises T-cell immune responses
por: Hu, Yan, et al.
Publicado: (2017)

Primary Macronodular Adrenal Hyperplasia Associated With Autosomal Dominant ARMC5 Mutation
por: Kerut, Sarah Elizabeth, et al.
Publicado: (2021)

Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations
por: Tang, Peng, et al.
Publicado: (2023)

SAT-197 Unilateral Adrenalectomy Can Induce Control in ARMC5 Mutations Patients
por: Ferreira, Maria João, et al.
Publicado: (2020)

ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia
por: Lao, Linjiang, et al.
Publicado: (2022)

MON-250 Late Diagnosis of ACTH-secreting Pulmonary Neuroendocrine Tumor by Repeated (68)Ga Dotatate Pet/ct: Influence of Tumor Size in Abnormal Uptake?
por: Andrade, Natália Xavier S, et al.
Publicado: (2020)

Characterization of a Novel Plasmid, pMAH135, from Mycobacterium avium Subsp. hominissuis
por: Uchiya, Kei-ichi, et al.
Publicado: (2015)

OR04-3 Genetic Alterations of ARMC5 and KDM1A Are Associated With Different Expression Profiles of Illegitimate Receptors in Primary Bilateral Macronodular Adrenal Hyperplasia
por: Armignacco, Roberta, et al.
Publicado: (2022)

ARMC5 mutation in a Portuguese family with primary bilateral macronodular adrenal hyperplasia (PBMAH)
por: Rego, Teresa, et al.
Publicado: (2017)

A novel nonsense mutation in ARMC5 causes primary bilateral macronodular adrenocortical hyperplasia
por: He, Wen-Tao, et al.
Publicado: (2021)

SAT-193 Clinical Case of ARMC5 Tumor Syndrome: A Rare Case of Cushing’s Syndrome from Primary Bilateral Macronodular Adrenal Hyperplasia Caused by ARMC5 Mutation with Concomitant Presence of Meningiomas and Primary Hyperparathyroidism
por: Parikh, Sahil, et al.
Publicado: (2020)

Allelic Variant of Armadillo Repeat Containing Protein 5 (ARMC5) in Myelolipoma Mimicking Pheochromocytoma: A Case Report
por: Naser, Nejat, et al.
Publicado: (2023)

Long-term Results after CT-Guided Percutaneous Ethanol Ablation for the Treatment of Hyperfunctioning Adrenal Disorders
por: Frenk, Nathan Elie, et al.
Publicado: (2016)

MicroRNA expression signature and target prediction in familial and sporadic primary macronodular adrenal hyperplasia (PMAH)
por: Tan, Xiao-Gang, et al.
Publicado: (2022)

ARMC5 Primary Bilateral Macronodular Adrenal Hyperplasia Associated with a Meningioma: A Family Report
por: Ferreira, M. J., et al.
Publicado: (2020)

ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors
por: Okuno, Yosuke, et al.
Publicado: (2022)

OR12-3 Identification of Predictive Criteria for the Primary Bilateral Macronodular Adrenal Hyperplasia Gene ARMC5: A European Series of 352 Unselected Patients.
por: Assié, Guillaume, et al.
Publicado: (2022)

Deubiquitylation and stabilization of ARMC5 by ubiquitin‐specific processing protease 7 (USP7) are critical for RCC proliferation
por: Yan, Guobei, et al.
Publicado: (2021)

A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing
por: Eghbali, Maryam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7i2780udtis7923dd6hbi3ra5n